ImmuCell Corp (ICCC)
5.42
+0.13
(+2.46%)
USD |
NASDAQ |
May 10, 16:00
5.42
0.00 (0.00%)
After-Hours: 18:26
ImmuCell Cash from Operations (TTM): -4.674M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.674M |
| September 30, 2023 | -5.249M |
| June 30, 2023 | -5.999M |
| March 31, 2023 | -4.944M |
| December 31, 2022 | -1.544M |
| September 30, 2022 | 0.3418M |
| June 30, 2022 | 1.859M |
| March 31, 2022 | 2.216M |
| December 31, 2021 | 0.9542M |
| September 30, 2021 | 0.5225M |
| June 30, 2021 | -0.4038M |
| March 31, 2021 | -0.1654M |
| December 31, 2020 | 1.316M |
| September 30, 2020 | 1.113M |
| June 30, 2020 | 1.714M |
| March 31, 2020 | 0.4138M |
| December 31, 2019 | 0.2335M |
| September 30, 2019 | 0.1418M |
| June 30, 2019 | -0.2977M |
| March 31, 2019 | 0.0541M |
| December 31, 2018 | -0.3734M |
| September 30, 2018 | 0.0957M |
| June 30, 2018 | 0.3465M |
| March 31, 2018 | 0.1701M |
| December 31, 2017 | 1.176M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.4731M |
| June 30, 2017 | 0.7119M |
| March 31, 2017 | 1.120M |
| December 31, 2016 | -0.2223M |
| September 30, 2016 | 0.9799M |
| June 30, 2016 | 1.548M |
| March 31, 2016 | 1.411M |
| December 31, 2015 | 2.900M |
| September 30, 2015 | 2.322M |
| June 30, 2015 | 1.490M |
| March 31, 2015 | 1.399M |
| December 31, 2014 | 0.3024M |
| September 30, 2014 | 0.1343M |
| June 30, 2014 | 0.4931M |
| March 31, 2014 | 0.9582M |
| December 31, 2013 | 1.099M |
| September 30, 2013 | 1.178M |
| June 30, 2013 | 0.961M |
| March 31, 2013 | 0.5978M |
| December 31, 2012 | 0.3444M |
| September 30, 2012 | 0.4762M |
| June 30, 2012 | 0.2557M |
| March 31, 2012 | -0.0802M |
| December 31, 2011 | -0.0373M |
| September 30, 2011 | -0.7535M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-5.999M
Minimum
Jun 2023
2.216M
Maximum
Mar 2022
-0.6554M
Average
0.2335M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |